CAGNACCI, ANGELO
 Distribuzione geografica
Continente #
EU - Europa 14.892
AS - Asia 2.012
NA - Nord America 752
SA - Sud America 147
AF - Africa 33
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 17.842
Nazione #
IT - Italia 14.380
SG - Singapore 855
US - Stati Uniti d'America 718
CN - Cina 567
VN - Vietnam 371
FR - Francia 190
CH - Svizzera 138
BR - Brasile 90
FI - Finlandia 86
HK - Hong Kong 73
DE - Germania 27
AR - Argentina 26
IN - India 22
MX - Messico 17
ID - Indonesia 15
BD - Bangladesh 13
NL - Olanda 12
TH - Thailandia 12
EC - Ecuador 11
IQ - Iraq 11
ZA - Sudafrica 11
JP - Giappone 10
GB - Regno Unito 9
UZ - Uzbekistan 9
KR - Corea 8
AT - Austria 7
CA - Canada 7
PH - Filippine 7
BE - Belgio 6
CO - Colombia 6
PK - Pakistan 6
CL - Cile 5
MA - Marocco 5
PY - Paraguay 5
TR - Turchia 5
UA - Ucraina 5
DK - Danimarca 4
DZ - Algeria 4
JM - Giamaica 4
PL - Polonia 4
PT - Portogallo 4
AU - Australia 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
RU - Federazione Russa 3
TW - Taiwan 3
ES - Italia 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
SI - Slovenia 2
TJ - Tagikistan 2
VE - Venezuela 2
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
EG - Egitto 1
ET - Etiopia 1
FJ - Figi 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TL - Timor Orientale 1
TN - Tunisia 1
UG - Uganda 1
UY - Uruguay 1
Totale 17.842
Città #
Genova 8.034
Genoa 4.064
Vado Ligure 1.267
Rapallo 834
Singapore 345
San Jose 280
Lauterbourg 181
Zurich 136
Ho Chi Minh City 102
Hanoi 87
Bordighera 84
Helsinki 83
Ashburn 82
Council Bluffs 75
Hong Kong 71
New York 44
St Louis 40
Beijing 39
Santa Clara 35
Da Nang 14
Haiphong 14
Frankfurt am Main 13
Milan 11
Bologna 9
Mexico City 9
Tashkent 9
São Paulo 8
Tokyo 8
Los Angeles 7
Biên Hòa 6
Brussels 6
Can Tho 6
Jakarta 6
Quito 6
Bangkok 5
Mumbai 5
Tianjin 5
Campinas 4
Guangzhou 4
Johannesburg 4
Ninh Bình 4
Orem 4
Quận Ba 4
Rio de Janeiro 4
Schiffdorf 4
Thái Nguyên 4
Amman 3
Amsterdam 3
Baghdad 3
Brasília 3
Cape Town 3
Cardiff 3
Chengdu 3
Dublin 3
Erbil 3
González Catán 3
Hải Dương 3
Kingston 3
Lappeenranta 3
Lisbon 3
Nairobi 3
Naples 3
Olzano 3
Palermo 3
Quảng Ngãi 3
Quận Bình Thạnh 3
Santiago 3
Seregno 3
Suzhou 3
Thái Bình 3
Vĩnh Long 3
Ankara 2
Asan 2
Atlanta 2
Bedford 2
Buenos Aires 2
Bình Phước 2
Bến Tre 2
Changsha 2
Chiang Mai 2
Cinisello Balsamo 2
City of London 2
Córdoba 2
Dallas 2
Delhi 2
Dhaka 2
Dushanbe 2
Feira de Santana 2
Guayaquil 2
Hưng Yên 2
Itapoá 2
Jiaxing 2
Karachi 2
Kuala Lumpur 2
Kyiv 2
La Spezia 2
Lahore 2
Leonding 2
Ljubljana 2
Macapá 2
Totale 16.199
Nome #
Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? 169
Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during the complete lockdown 161
Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study 149
Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study 145
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 143
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study 137
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 136
Age at menopause, extent of coronary artery disease and outcome among postmenopausal women with acute coronary syndromes 136
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 135
Adenomyosis of the Extrapelvic Portion of the Round Ligament 134
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 134
Association between urinary incontinence and climacteric symptoms in postmenopausal women 133
Dienogest mediates midkine suppression in endometriosis 132
Angle of Uterine Flexion and Adenomyosis 130
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 127
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 126
Association between pelvic organ prolapse and climacteric symptoms in postmenopausal women 124
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 123
Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives? 121
Vasomotor symptoms and management of women undergoing treatment for breast cancer: literature review with focus on the therapeutic potential of cytoplasmic pollen extract 119
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 118
Recommendations for contraception in women with diabetes. AMD-SIC position paper 117
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 117
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (.) 115
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 115
Oral contraceptives and insulin sensitivity 115
A comparison of the central effects of different progestins used in hormone replacement therapy 114
Integrated Clinical Pathways in vaginal and caesarean delivery: effect analysis 2016-2017, Italy 113
Anthropometric Features and Third-Fourth Degree Perineal Tears 112
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 111
Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study 110
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 110
Hormone replacement therapy and prevention of chronic conditions 109
The Controversial History of Hormone Replacement Therapy 109
Intermenstrual pelvic pain, quality of life and mood 108
Seasonal trend of acute pelvic inflammatory disease 108
The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study 108
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 107
Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women 107
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study 106
Gut Microbiota and Endometriosis: Exploring the Relationship and Therapeutic Implications 105
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status 105
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 104
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 103
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 103
The relation of season of birth to severity of menopausal symptoms 103
Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO) 103
Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels 102
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 102
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 102
Pharmacokinetic evaluation of desogestrel as a female contraceptive 102
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 101
Kava-Kava administration reduces anxiety in perimenopausal women 101
Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis 101
Medical and patient attitude towards vaginal atrophy: the AGATA study 99
Seasonal onset of the menopause 98
Management of vaginal atrophy: a real mess. Results from the AGATA study 97
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 97
Menstrual Pain and Elasticity of Uterine Cervix 97
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study 96
Relationship between urinary estrogen levels before conception and sex ratio at birth in a primate, the gray mouse lemur 95
The Benefit of Transvaginal Elastography in Detecting Deep Endometriosis: A Feasibility Study 94
European society of contraception statement on contraception in obese women 94
Massive Hemoperitoneum from Uterine Leiomyoma Associated with Diffuse Myometrial Venous Congestion 94
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause 94
Contraception in cancer survivors–an expert review Part II. Skin, gastrointestinal, haematological and endocrine cancers 94
Role of close endocervical margin in treatment failure after cervical excision for cervical intraepithelial neoplasia: A retrospective study 94
Influences of maternal weight on the secondary sex ratio of human offspring 93
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 93
Folate administration decreases oxidative status and blood pressure in postmenopausal women 93
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 93
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function 92
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 92
Chronic pelvic pain improvement: impact on quality of life and mood 92
Small fetal thymus and adverse obstetrical outcome: a systematic review and a meta-analysis 92
Vaginal atrophy across the menopausal age: results from the ANGEL study 91
Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case-control study 91
Prevalence of menstrual pain in young women: what is dysmenorrhea 91
Age-related difference in the rate of coronavirus disease 2019 mortality in women versus men 91
Maternal and perinatal outcomes in high compared to low risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection (phase 2): the World Association of Perinatal Medicine working group on coronavirus disease 2019 91
History of vasomotor symptoms, extent of coronary artery disease, and clinical outcomes after acute coronary syndrome in postmenopausal women 90
Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women 90
Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation 89
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 89
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 89
Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors 88
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 88
Prolonged melatonin administration decreases nocturnal blood pressure in women 88
Season of birth influences the timing of menopause 88
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures 88
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 88
Role of melatonin in circadian rhythm at menopause 88
Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis 88
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 87
Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance 87
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 87
Omentum incarceration in uterine perforation: from diagnosis to therapy 86
Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study 86
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 86
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 86
Totale 10.574
Categoria #
all - tutte 74.498
article - articoli 73.394
book - libri 0
conference - conferenze 388
curatela - curatele 0
other - altro 411
patent - brevetti 0
selected - selezionate 0
volume - volumi 305
Totale 148.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021471 0 0 0 0 0 0 0 0 0 248 124 99
2021/20221.751 91 38 46 163 33 221 27 429 242 113 104 244
2022/20231.268 213 64 5 83 126 134 14 79 216 12 288 34
2023/2024823 44 120 26 92 68 35 35 92 29 32 66 184
2024/20252.967 67 318 71 92 521 327 316 285 178 207 188 397
2025/20264.943 606 141 329 342 488 627 858 454 505 593 0 0
Totale 18.399